Abstract
Hematopoietic stem cell transplant patients represent a population at high risk for drug-related problems. Our objective is to describe pharmacist interventions in a hematopoietic stem cell transplant pediatric unit. METHODS AND PATIENTS. The Hematopoietic Stem Cell Transplant Unit of the Centre Hospitalier Universitaire Sainte-Justine performs around 50 hematopoietic stem cell transplants per year. During a pharmaceutical care specialized residency program, a French pharmacist participated in certain clinical activities. Drug-related problems and clinical interventions were compiled over 31 nonconsecutive days using a tool developed by the Société Française de Pharmacie Clinique. Data concerning patients, drugs, intervention, documentation, approval (if needed), and estimated impact were compiled. During the 31-day period, 525 interventions were collected (16.9 +/- 3.7 per day), targeting 29 patients. The main drug-related problems were adverse drug reactions (N = 125, 23.8%), untreated indication (N = 92, 17.5%) and failure to receive drug (N = 89, 17.0%). The pharmacist's interventions concerned mainly dose adjustment (N = 174, 33.1%) and drug monitoring (N = 132, 25.1%). Among the 324 (61.7%) interventions requiring a physi...Continue Reading
References
Apr 1, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·B J Holcombe
Aug 26, 1998·Journal of the American Pharmaceutical Association : APhA·J A WaddellM K Wray
Oct 8, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·R W Holland, C M Nimmo
Jun 20, 2001·Pharmacy World & Science : PWS·H Boardman, R Fitzpatrick
Mar 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Helen T WuCourtney W Yuen
Aug 3, 2006·The Annals of Pharmacotherapy·Sachin ShahShane Greene
Sep 21, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Eva Rämme BrembergStaffan Eksborg
Oct 27, 2006·Pharmacy World & Science : PWS·Benoît AllenetOrnella Conort
Jan 30, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S Prot-LabartheF Brion
Feb 27, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jean-François BussièresDiane Larocque
Apr 26, 2007·Pharmacy World & Science : PWS·Sonia Prot-LabartheOlivier Bourdon
Jun 6, 2007·Bone Marrow Transplantation·S Prot-LabartheC Joubert
Oct 19, 2007·Pharmacy World & Science : PWS·Sonia Prot-LabartheOlivier Bourdon
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·A Ghanizadeh
Jul 16, 2008·Pharmacology & Therapeutics·Gary A Gintant
Citations
Dec 25, 2012·International Journal of Clinical Pharmacy·Sonia Prot-LabartheOlivier Bourdon
Oct 4, 2012·The Annals of Pharmacotherapy·Kristin L ReppMichael A Borkon
Feb 23, 2018·International Journal of Clinical Pharmacy·Bharath R RavichandranBrian M Masters
Jul 1, 2016·World Journal of Transplantation·Kwi Suk KimSang Geon Kim
Jun 13, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Maria Olívia Barboza-ZanettiLeonardo Régis Leira-Pereira
Oct 9, 2012·Journal of Pediatric Hematology/oncology·Sonia Prot-LabartheOlivier Bourdon
Dec 12, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Cynara S OliveiraRenata F de Araújo-Calumby
Nov 21, 2018·Bulletin du cancer·Edouard ForcadeNicolas Simon